Compugen
CGEN
$1.98
Share price
4.76%
Change (1 day)
224.59%
Change (1 year)
Categories
P/S ratio for Compugen (CGEN)
P/S ratio as of April 2024 (TTM): 5.39
According to Compugen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.38863. At the end of 2023 the company had a P/S ratio of 5.23.
P/S ratio history for Compugen from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.23 | -36.87% |
| 2022 | 8.28 | -86.15% |
| 2021 | 59.8 | -88.06% |
| 2020 | 501 | |
| 2019 | N/A | -100% |
| 2018 | 7.56 | |
| 2017 | N/A | -100% |
| 2016 | 366 | 972.79% |
| 2015 | 34.1 | 0.48% |
| 2014 | 34.0 | -66.33% |
| 2013 | 101 | -86.52% |
| 2012 | 749 | |
| 2011 | N/A | -100% |
| 2010 | 171 | -73.26% |
| 2009 | 638 | 1657.87% |
| 2008 | 36.3 | -84.39% |
| 2007 | 232 | -1.23% |
| 2006 | 235 | 467.05% |
| 2005 | 41.5 | 17.02% |
| 2004 | 35.5 | 130.82% |
| 2003 | 15.4 | 266.99% |
| 2002 | 4.19 | -61.18% |
| 2001 | 10.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | 18.8 | 248.14% | 🇺🇸 USA |
 Genetic Technologies GENE | 0.6065 | -88.75% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | 0.9206 | -82.92% | 🇮🇱 Israel |
 Eterna Therapeutics ERNA | 175 | 3,148.32% | 🇺🇸 USA |